Abstract
Many patients with metastatic or treatment-resistant cancer have experienced improved outcomes after immunotherapy that targets adaptive immune checkpoints. However, innate immune checkpoints, which can hinder the detection and clearance of malignant cells, are also crucial in tumor-mediated immune escape and may also serve as targets in cancer immunotherapy. In this review, we discuss the current understanding of immune evasion by cancer cells via disruption of phagocytic clearance, and the potential effects of blocking phagocytosis checkpoints on the activation of antitumor immune responses. We propose that a more effective combination immunotherapy strategy could be to exploit tumor-intrinsic processes that inhibit key innate immune surveillance processes, such as phagocytosis, and incorporate both innate and adaptive immune responses for treating patients with cancer.
Original language | English (US) |
---|---|
Pages (from-to) | 650-665 |
Number of pages | 16 |
Journal | Trends in Cancer |
Volume | 9 |
Issue number | 8 |
DOIs | |
State | Published - Aug 2023 |
Keywords
- adaptive immunity
- dendritic cells
- innate immunity
- macrophages
- phagocytic checkpoints
ASJC Scopus subject areas
- Oncology
- Cancer Research